Ambipar Financial Statements From 2010 to 2024

AMBI Stock  USD 5.56  0.51  10.10%   
Ambipar Emergency financial statements provide useful quarterly and yearly information to potential Ambipar Emergency Response investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Ambipar Emergency financial statements helps investors assess Ambipar Emergency's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Ambipar Emergency's valuation are summarized below:
Ambipar Emergency Response does not presently have any fundamental signals for analysis.
Check Ambipar Emergency financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ambipar Emergency's main balance sheet or income statement drivers, such as , as well as many indicators such as . Ambipar financial statements analysis is a perfect complement when working with Ambipar Emergency Valuation or Volatility modules.
  
Check out the analysis of Ambipar Emergency Correlation against competitors.

Ambipar Emergency Response Company Current Valuation Analysis

Ambipar Emergency's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Ambipar Emergency Current Valuation

    
  630.96 M  
Most of Ambipar Emergency's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ambipar Emergency Response is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Ambipar Emergency Response has a Current Valuation of 630.96 M. This is 91.34% lower than that of the Commercial Services & Supplies sector and significantly higher than that of the Industrials industry. The current valuation for all United States stocks is 96.2% higher than that of the company.

Ambipar Emergency Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ambipar Emergency's current stock value. Our valuation model uses many indicators to compare Ambipar Emergency value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ambipar Emergency competition to find correlations between indicators driving Ambipar Emergency's intrinsic value. More Info.
Ambipar Emergency Response is rated third in return on equity category among its peers. It is number one stock in return on asset category among its peers reporting about  0.63  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Ambipar Emergency Response is roughly  1.58 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ambipar Emergency's earnings, one of the primary drivers of an investment's value.

About Ambipar Emergency Financial Statements

Investors use fundamental indicators, such as Ambipar Emergency's revenue or net income, to determine how well the company is positioned to perform in the future. Although Ambipar Emergency's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Ambit Biosciences Corporationration, a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of oncology, autoimmune, and inflammatory diseases in the United States.

Currently Active Assets on Macroaxis

When determining whether Ambipar Emergency offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ambipar Emergency's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ambipar Emergency Response Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ambipar Emergency Response Stock:
Check out the analysis of Ambipar Emergency Correlation against competitors.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Waste Management space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ambipar Emergency. If investors know Ambipar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ambipar Emergency listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Ambipar Emergency is measured differently than its book value, which is the value of Ambipar that is recorded on the company's balance sheet. Investors also form their own opinion of Ambipar Emergency's value that differs from its market value or its book value, called intrinsic value, which is Ambipar Emergency's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ambipar Emergency's market value can be influenced by many factors that don't directly affect Ambipar Emergency's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ambipar Emergency's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ambipar Emergency is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ambipar Emergency's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.